Semaglutide and Alzheimer’s Disease: Phase 3 Trial Updates
January 19, 2026
Understanding Semaglutide’s Potential Role in Alzheimer’s DiseaseSemaglutide is a medication initially approved for managing type 2 diabetes and obesity. It belongs to a [...]